LLM returned non-JSON response. Review the filing manually.
Price Chart
Executive Summary
{ "summary": "Turning Point Brands reported Q2 2026 results with Modern Oral net sales surging 128% to $68.4M (48% of total, up from 26%), driving total revenue growth of 22.6% to $142.9M. However, heavy investment in sales and marketing caused GAAP net income to plunge 75.2% to $3.6M ($0.18 diluted EPS) and Adjusted EBITDA to drop 50% to $15.2M. The company raised FY 2026 Modern Oral net sales guidance to $260-270M (from $210-225M), maintained overall Adjusted EBITDA guidance of $70-90M, and
Financial Impact
Unknown
Risk Factors
- Analysis may be incomplete
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-025512 |
| Document: tpb20260528_8k.htm | 0001437749-26-025512 |
| Document: 0001437749-26-025512-index-headers.html | 0001437749-26-025512 |
| Document: 0001437749-26-025512-index.html | 0001437749-26-025512 |
| Document: 0001437749-26-025512.txt | 0001437749-26-025512 |
| 8-K Data (Synthetic) | 0001437749-26-025512 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 12w ago | 8-K | $82.48 $77.72 | ▼ −5.77% | ▼ −4.53% | $67.34 (−18.36%) |
May 7, 2026 24w ago | 8-K | $90.22 $86.24 | ▼ −4.41% | ▼ −7.55% | $67.34 (−25.36%) |
Feb 28, 2026 34w ago | Institutional Cluster | $108.41 $86.22 | ▼ −20.47% | ▼ −12.53% | $67.34 (−37.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers